(Q38921107)

7 September 2017

title

What can economics add to health technology assessment? Please not just another cost-effectiveness analysis! (English)

1 reference

7 September 2017

John Fp Bridges

1

1 reference

7 September 2017

publication date

1 February 2006

1 reference

Expert Review of Pharmacoeconomics & Outcomes Research

7 September 2017

published in

1 reference

7 September 2017

volume

6

1 reference

7 September 2017

issue

1

1 reference

7 September 2017

page(s)

19-24

1 reference

History and development of evidence-based medicine

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Why we need observational studies to evaluate the effectiveness of health care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

The development of health technology assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Health technology assessment in Canada. A decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

The death of cost-minimization analysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Developing guidance for budget impact analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Budget impact analysis: review of the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Valuing the benefits and costs of health care programmes: where's the 'extra' in extra-welfarism?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

The QALY--a measure of social value rather than individual utility?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Future challenges for the economic evaluation of healthcare: patient preferences, risk attitudes and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Non-clinical safety evaluation of novel vaccines and adjuvants: new products, new strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Building uncertainty into cost-effectiveness rankings: portfolio risk-return tradeoffs and implications for decision rules

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Mathematical programming for the efficient allocation of health care resources.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

Complexity science: complexity and clinical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

The General Theory of Second Best

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

The burden of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

The measurement of patients' values in medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737167.6.1.19

21 January 2018

Identifiers

DOI

10.1586/14737167.6.1.19

1 reference

7 September 2017

1 reference